Systemic allergic reaction due to intranasal budesonide.

نویسندگان

  • G Davila-Fernández
  • S Vazquez-Cortés
  • M Chamorro-Gómez
  • A Elices-Apellániz
چکیده

Topical corticosteroids are frequently recognised as a cause of allergic contact dermatitis but in only few cases the administration of intranasal corticosteroids has been reported as the cause of systemic allergic reaction.1--6 A 34-year-old non-atopic woman started treatment with nasal budesonide for a common cold. On the second day of treatment the patient developed, 8 h after the administration of 256 mcg (two puff per nostril each time), lips, nose, and eyelid angioedema and pruritic urticarial papules in face, chest and arms. The symptoms remitted gradually over 3--4 days after treatment with hydroxyzine. Previously the patient had tolerated nasal budesonide without adverse effects. Prick and intradermal test were performed with a battery of corticosteroids (hydrocortisone, methylprednisolone, budesonide, triamcinolone, deflazacort and dexamethasone) (Table 1) with the excipients carboxymethylcellulose, Tween 80, and benzylalcohol. Prick tests were considered positive when a wheal of more than 3 mm in diameter was present 15 min later. When prick test responses were negative 0.02--0.05 ml of the reagent solution was injected intradermally. Readings were made 20 min after injection. Results were considered positive when wheal and erythema greater than 5 mm were present. Positive control for prick and intradermal tests were done with histamine, at 10 mg/ml and 1 mg/ml respectively. Sterile 0.9% saline was used as a negative control. Ten non-atopic and ten atopic subjects were also tested as a control.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Intranasal application of glucocorticoid alleviates olfactory dysfunction in mice with allergic rhinitis

The aim of the present study was to investigate the effect of glucocorticoid intervention on olfactory dysfunction in mice with allergic rhinitis (AR). An AR animal model was established by intraperitoneal injection and intranasal application of ovalbumin to mice. The olfactory function of the mice was evaluated using a buried food test, and morphological changes in the nasal mucosa were determ...

متن کامل

Inhaled and intranasal fluticasone propionate and haematoma

Fluticasone propionate is a locally acting potent corticosteroid and is registered in the Netherlands since November 1990. It is marketed as nasal drops and nasal spray (Flixonase) for the indications vasomotor and allergic rhinitis, nasal polyps, and as inhalation corticosteroid (ICS) (Flixotide) in both an inhalation dosisaerosol and a powder inhalation form for indications asthma and chronic...

متن کامل

Intranasal corticosteroids for allergic rhinitis

• Allergic rhinitis is defined as intermittent (or seasonal) or persistent (or perennial), according to symptom duration and frequency. • Intranasal corticosteroids are the most effective treatment option for moderate-severe symptoms and reduce sneezing, rhinorrhea, itching, post-nasal drip and nasal blockage, and total nasal symptom scores better than antihistamines. • There are currently six ...

متن کامل

Immunotherapy of Chenopodium Album Induced Asthma by Intranasal Administration of CpG Oligodeoxynucleotides in BALB/c Mice

Background: There are many therapeutic methods for allergic conditions. CpG oli-gonucleotides play a critical role in immunity via the augmentation of Th1 and suppres-sion of Th2 responses. Objective: In the present study we aimed to estimate the effec-tiveness of intranasal administration of CpG ODN plus Chenopodium album allergen in allergic asthma compared with the administration of allergen...

متن کامل

Is the use of intranasal glucocorticosteroids (inGCSs) in children safe?

It's been 40 years since Niels Mygind publication in British Medical Journal on intranasal application of beclomethasonedipropionate aerosol in Allergic Rhinitis. Since then the new era in treatment of allergic and non-allergic upper airway diseases has begun. This publication presents current concepts on application of intranasal glucocorticosteroids in treatment of upper airway diseases and i...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Allergologia et immunopathologia

دوره 40 6  شماره 

صفحات  -

تاریخ انتشار 2012